Albaba Isam, Medarov Boris I
Department of Medicine, Albany Medical College, Albany, NY, USA.
Division of Pulmonary and Critical Care Medicine, Albany Medical College, Albany, NY, USA.
Respir Med Case Rep. 2022 May 23;38:101671. doi: 10.1016/j.rmcr.2022.101671. eCollection 2022.
Pulmonary hypertension (PH) in cancer patients can be caused by several mechanisms. It can be a direct cancer effect through pulmonary tumor thrombotic microangiopathy, pulmonary tumor emboli, extrinsic compression, intravascular tumors, or a secondary consequence of therapy, including chemotherapy agents, radiation, and stem cell transplantation. We present the first case of complete resolution of cancer-related PH.
癌症患者的肺动脉高压(PH)可由多种机制引起。它可能是由肺部肿瘤血栓性微血管病、肺部肿瘤栓子、外部压迫、血管内肿瘤导致的直接癌症效应,也可能是治疗的继发性后果,包括化疗药物、放疗和干细胞移植。我们报告了首例癌症相关PH完全缓解的病例。